Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
NTRA News
In a report released yesterday, Kyle Mikson CFA from Canaccord Genuity maintained a Buy rating on Natera, with a price target of $200.00. Elevate Your Investing...
Mark Massaro, an analyst from BTIG, reiterated the Buy rating on Natera. The associated price target was raised to $210.00. Elevate Your Investing Strategy: Tak...
BTIG analyst Mark Massaro raised the firm’s price target on Natera (NTRA) to $2 10 from $200 and keeps a Buy rating on the shares. The firm is positive on Nater...
Analyst ratings
90%
of 21 ratingsMore NTRA News
Natera stock has captured a lot of attention lately and for good reason. If you’re holding shares or considering jumping in, you’ve probably noticed the numbers...
(RTTNews) - Natera Inc. (NTRA) announced results from the randomized, double-blind, phase 3 IMvigor011 clinical trial in muscle-invasive bladder cancer (MIBC)....
Natera, Inc. recently presented significant clinical data at the ESMO Congress 2025 in Berlin and was recognized by Fast Company for its Signatera molecular res...
Natera (NTRA) just landed on Fast Company’s 2025 Next Big Things in Tech list, recognized for its Signatera molecular residual disease test for cancer. This typ...